Skip to content

A Study to Evaluate Visually Inspired Patient Education Material on Willingness to Pursue Radiation Therapy

A Randomized Clinical Trial to Study the Utility of Visually Inspired Patient Education Material on Willingness to Pursue Radiation Therapy in American Indian and Alaska Native Individuals (VIEW Study)

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04839679
Enrollment
51
Registered
2021-04-09
Start date
2021-03-30
Completion date
2025-04-01
Last updated
2025-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patient Education in Radiation Oncology

Keywords

Radiation therapy, Patient education, Radiation oncology, Native Americans

Brief summary

This research study is being done in order to better understand and identify American Indian/Alaskan Native (AI/AN) cancer patients' attitudes and beliefs towards radiation therapy treatment plans and their willingness to pursue them.

Interventions

BEHAVIORALCulturally Oriented Educational Brochure

Culturally appropriate educational brochure summarizing pertinent treatment information in a visual manner

BEHAVIORALMayo Clinic Educational Booklet

An Introduction to Radiation Simulation and Treatment- Barbara Woodward Lips, Patient Education Center

Sponsors

Mayo Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient at least 18 years of age with cancer diagnosis. * Radiation therapy is recommended for their cancer treatment as a next step in their cancer care. * Cognitive capacity to complete a paper-and-pencil survey. * Ability to communicate and understand English with proficiency to provide informed consent and complete a paper-and-pencil survey.

Exclusion criteria

* Patient \< 18 years of age. * Patient does not have a cancer diagnosis.

Design outcomes

Primary

MeasureTime frameDescription
Change in patient anxietyBaseline, day 14Measured using self-reported Hospital Anxiety and Depression Scale (HADS) Survey to ascertain any anxiety and/or depression that they may be experiencing with respect to their diagnosis and treatment. Questionnaire total score reported on a scale of 0-7 = normal, 8-10 borderline abnormal (borderline case), 11-21 abnormal (case)
Radiotherapy completion rates in the AI/AN community90 daysNumber of participates to complete radiation therapy as prescribed
Change in patient perception of information receivedBaseline, day 14Measured by the EORTC QLQ - INFO25 survey, which is a validated instrument that will gauge their satisfaction with the information they received regarding their diagnosis and treatment plan. Questionnaire of 24 questions regarding information received during treatment using a scale of 1 (not at all) to 4 (very much).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026